Other ways to assess RP

Article

Metrics other than visual acuity (VA) and visual field (VF) may be useful for assessing retinitis pigmentosa (RP), according to study results published in the February issue of Eye.

Metrics other than visual acuity (VA) and visual field (VF) may be useful for assessing retinitis pigmentosa (RP), according to study results published in the February issue of Eye.

H Nakamura, of the Department of Ophthalmology and Visual Sciences at Kyoto University Graduate School of Medicine, Japan, and colleagues conducted a cross-sectional observational study evaluating the foveal and macular function of three groups of RP patients (n=56), which they assessed using optical coherence tomography (OCT) and focal electroretinogram (fERG) as well as VA and VF tests. The groups were divided as follows: those with no photoreceptor inner/outer segment junction (IS/OS) visible on OCT (Group 1, n=22); those with IS/OS of ≤2 mm (Group 2, n=18), and those with >2 mm IS/OS (Group 3, n=16).

Group 1 patients showed non-recordable fERG and a significantly lower average VA than Group 2 and 3 patients, who had similar VA scores and, on the whole, demonstrated recordable fERG amplitudes. The differences between the amplitudes registered by each group differed significantly, although no implicit time differences between Groups 2 and 3 were shown.

The researchers therefore concluded that, in addition to the traditional VA and VF analysis, fERG amplitudes and an OCT analysis of the IS/OS may aid in assessing foveal and macular function in RP.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.